Related Experiment Videos

The use of biomarkers in the patient with heart failure

Punam Chowdhury1, Devin Kehl, Rajiv Choudhary

  • 1San Diego Veteran's Affairs Medical Center, San Diego, CA 92161, USA. cPunam80@yahoo.com

Current Cardiology Reports
|May 7, 2013
PubMed

Insights

Biomarkers are crucial for identifying, stratifying, and managing heart failure patients. This review covers established and emerging biomarkers for improved heart failure diagnosis and prognosis.

Area of Science:

  • Cardiology
  • Biomarker Research
  • Clinical Medicine

Background:

  • Heart failure presents a significant healthcare burden due to high costs, morbidity, and mortality.
  • Effective management relies on rapid patient identification and risk stratification.
  • Biomarkers play a critical role in achieving these goals for acute and chronic heart failure.

Purpose of the Study:

  • To review biomarkers with significant diagnostic, prognostic, and therapeutic value in heart failure.
  • To discuss established biomarkers like natriuretic peptides.
  • To explore emerging biomarkers related to myocyte stress, injury, extracellular matrix, and cardio-renal physiology.

Main Methods:

  • Literature review of established and emerging heart failure biomarkers.
  • Analysis of biomarker utility in diagnosis, prognosis, and therapeutic guidance.
  • Focus on natriuretic peptides, myocyte injury markers, and cardio-renal indicators.

Main Results:

  • Natriuretic peptides are established biomarkers with proven value.
  • Emerging biomarkers offer insights into myocyte stress, injury, and extracellular matrix remodeling.
  • Biomarkers reflecting neurohormonal and cardio-renal interactions are increasingly important.

Conclusions:

  • Appropriate biomarker utilization is essential for optimal heart failure patient care.
  • A comprehensive understanding of both established and emerging biomarkers aids in diagnosis and risk stratification.
  • Future research directions include further validation of novel biomarkers for heart failure management.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...